34.14
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$34.22
Offen:
$33.86
24-Stunden-Volumen:
1.22M
Relative Volume:
0.57
Marktkapitalisierung:
$5.42B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-310.36
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
-6.47%
1M Leistung:
+6.16%
6M Leistung:
-11.12%
1J Leistung:
+49.54%
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Vergleichen Sie TGTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TGTX
Tg Therapeutics Inc
|
34.14 | 5.43B | 264.79M | -14.36M | -28.11M | -0.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
2025-07-10 | Fortgesetzt | Goldman | Neutral |
2024-10-29 | Eingeleitet | TD Cowen | Buy |
2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
2023-06-26 | Fortgesetzt | Jefferies | Buy |
2022-05-20 | Eingeleitet | BofA Securities | Underperform |
2022-02-23 | Bestätigt | B. Riley Securities | Buy |
2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
2021-04-20 | Eingeleitet | Goldman | Neutral |
2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
2020-09-01 | Eingeleitet | JP Morgan | Overweight |
2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
2019-02-06 | Fortgesetzt | Jefferies | Buy |
2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
2017-04-25 | Eingeleitet | Jefferies | Buy |
2017-03-06 | Bestätigt | FBR & Co. | Outperform |
2016-10-06 | Fortgesetzt | Brean Capital | Buy |
2016-05-27 | Eingeleitet | SunTrust | Buy |
2015-12-01 | Eingeleitet | FBR Capital | Outperform |
2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
2015-06-19 | Bestätigt | Brean Capital | Buy |
2014-12-11 | Bestätigt | ROTH Capital | Buy |
2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
How TG Therapeutics Inc. stock compares to industry benchmarksMarket Risk Analysis & Growth Focused Stock Reports - newser.com
TG Therapeutics Inc. stock chart pattern explainedPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-14 02:23:58 - newser.com
Is TG Therapeutics Inc. forming a bottoming baseWeekly Risk Report & Daily Chart Pattern Signals - newser.com
What candlestick patterns are forming on TG Therapeutics Inc.Market Trend Review & Growth Focused Stock Reports - newser.com
How risky is TG Therapeutics Inc. (NKB2) stock compared to peersMarket Growth Review & Growth-Oriented Investment Plans - newser.com
What dividend safety score for TG Therapeutics Inc. stockPortfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-13 09:09:08 - newser.com
Published on: 2025-10-13 08:45:12 - newser.com
TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring a 29% Upside in the Biotech Sector - DirectorsTalk Interviews
Can TG Therapeutics Inc. stock resist market sell offs2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com
Is TG Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & High Yield Equity Trading Tips - newser.com
Market reaction to TG Therapeutics Inc.’s recent newsMarket Performance Recap & Risk Controlled Stock Alerts - newser.com
What makes TG Therapeutics Inc. (NKB2) stock appealing to growth investorsMarket Risk Analysis & High Return Stock Watch Alerts - newser.com
Is TG Therapeutics Inc. still worth holding after the dipJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Is TG Therapeutics Inc. reversing from oversold territoryMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
What indicators show strength in TG Therapeutics Inc.Dividend Hike & Expert Approved Momentum Trade Ideas - newser.com
Analysts Offer Predictions for TG Therapeutics Q3 Earnings - MarketBeat
What analysts say about TG Therapeutics Inc stockEarnings Forecast Updates & Identify Breakout Stocks - earlytimes.in
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
HC Wainwright Weighs in on TG Therapeutics FY2029 Earnings - MarketBeat
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TGTX Receives 'Buy' Rating from HC Wainwright & Co. with $60 Pri - GuruFocus
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Significant Growth Potential - DirectorsTalk Interviews
Analyzing TG Therapeutics Inc. with risk reward ratio chartsQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Detecting support and resistance levels for TG Therapeutics Inc.July 2025 Drop Watch & Fast Moving Trade Plans - newser.com
Institutional investors are TG Therapeutics, Inc.'s (NASDAQ:TGTX) biggest bettors and were rewarded after last week's US$176m market cap gain - Yahoo Finance
What TG Therapeutics (TGTX)'s Six-Year BRIUMVI Safety Data Means For Shareholders - Yahoo Finance
A Look at TG Therapeutics (TGTX) Valuation Following Positive Six-Year BRIUMVI Trial Results - Sahm
TG Therapeutics, Inc.'s (NASDAQ:TGTX) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 5.8% Over Last Week - 富途牛牛
Key metrics from TG Therapeutics Inc.’s quarterly dataTrade Volume Summary & Precise Buy Zone Identification - newser.com
Can TG Therapeutics Inc. stock rebound after recent weaknessBear Alert & Real-Time Stock Movement Alerts - newser.com
What TG Therapeutics, Inc.'s (NASDAQ:TGTX) 26% Share Price Gain Is Not Telling You - Sahm
Is TG Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Rallies & Short-Term High Return Strategies - newser.com
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):